Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00185952 · ClinicalTrials.gov registry record · NA
Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.
A NA study of Venous Thrombosis and Obstetric Labor, Premature, sponsored by Stanford University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT00185952: Completed NA study of Venous Thrombosis and Obstetric Labor, Premature, sponsored by Stanford University.
NCT00185952 is a NA study of Venous Thrombosis and Obstetric Labor, Premature that has completed, run by Stanford University. The registered enrollment target is 70 participants, below the 1,117-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00185952, a NA study of Venous Thrombosis and Obstetric Labor, Premature, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
Comparing nifedipine to placebo for the maintenance tocolysis of preterm labor
Conditions Studied
Interventions
- DRUG Nifedipine
Study Locations (1)
California
- Stanford University School of Medicine - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2001-11 |
| Est. Completion | 2008-08 |
| Phase | NA |
What the finished NCT00185952 record still lists
NCT00185952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,117-participant average among 9 other Venous Thrombosis trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Venous Thrombosis appearing as the primary indexed condition, and to 1 intervention - of which Nifedipine is the first listed.
NCT00185952 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00185952 about?
NCT00185952 is a clinical study titled "Nifedipine vs Placebo for Maintenance Tocolysis of Preterm Labor.". Comparing nifedipine to placebo for the maintenance tocolysis of preterm labor
What is the current status of trial NCT00185952?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2001-11. Estimated completion is 2008-08.
What conditions does trial NCT00185952 study?
This clinical trial studies the following conditions: Venous Thrombosis, Obstetric Labor, Premature.
What interventions are being tested in trial NCT00185952?
The interventions under investigation include: Nifedipine (DRUG).
Who is sponsoring clinical trial NCT00185952?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00185952 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Venous Thrombosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00185952's enrollment target sits among peer trials
70 7th of 9 higher than 3 of 9 other Venous Thrombosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Venous Thrombosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Peripherally Inserted Central Catheter (PICC) Thrombosis: Reverse Taper Versus Non-tapered Catheters
COMPLETED · NA
-
Vasculaire Compression System Increases Flow Velocity in the Femoral Vein
COMPLETED · NA
-
JETi Lower Extremity Venous Thrombosis
ACTIVE NOT RECRUITING
-
Registry of AngioJet Use in the Peripheral Vascular System
COMPLETED
-
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
-
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia